SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL)
IMCL 0.1590.0%Oct 5 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (2082)2/21/2002 1:05:43 PM
From: 613  Read Replies (1) of 2515
 
I agree that the FDA is not to blame here. But they DID approve the trial without a placebo control group. So the 'only' thing that IMCL didn't do is prove that the patients were unresponsive to chemo. If IMCL can indeed 'prove' this with existing info not previously provided, why wouldn't they get approval?

And I wouldn't put it past Icahn and the Waksal's to put together some stunt to try to move the stock up or to pick it up even cheaper (single digits) if FDA says new trials are required in order to negotiate with BMY from a stronger position.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News